KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Krystal Biotech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$320.25+3.67 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $9.82B
- P/E (TTM)
- 40.1
- Dividend yield
- –
Dividends
Krystal Biotech has not reported a dividend
No dividend per share appears in Krystal Biotech's annual filings since fiscal 2016.